Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) vs Title X Family Planning Services Grants
Side-by-side comparison of two grants.
| Attribute | Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) | Title X Family Planning Services Grants |
|---|---|---|
| Type | Grant | Grant |
| Funding amount | — | $22M |
| Deadline | Closes 2027-12-23 | Closes 2027-01-11 |
| Region | US | US |
| Sector | Health | Health |
| Funder | National Institutes of Health | Office of the Assistant Secretary for Health |
| Who it's for | nonprofits, researchers, government | individuals, nonprofits |
noindex — no measured search demand